Institut Mérieux is contributing its experience in biology to improve medicine and public health across the globe.
To fight against infectious diseases and cancer, the Institute imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety, and nutrition.
Its three bio-industrial companies (bioMérieux, Transgene and Mérieux NutriSciences), working alongside its entity devoted to investment in healthcare (Mérieux Equity Partners), have contributed to major advances in medicine and public health.
Institut Mérieux employs 23,000 people around the world and is present in 45 countries, with 4.38 billion euros in sales.
Institut Mérieux
An independent family group
World headquarters located in Lyon (France)
4
companies dedicated to global public health
Established in 45 countries
93% of sales generated outside France
Core businesses:
in vitro diagnostics, food safety, immunotherapy, healthcare investment
23,000
employees worldwide
2023 sales:
€4.38 billion
Investment in R&D
11%
of sales